Nisa Investment Advisors
YARW

Nisa Investment Advisors’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Nisa Investment Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed -$2 – 2334
2021
Q2 		$2 Hold
1
– – ﹤0.01% 2306
2021
Q1 		$3 Hold
1
– – ﹤0.01% 2281
2020
Q4 		$3K Buy
+1
New +$6.28K ﹤0.01% 2281
2020
Q3 		– Hold
0
– – – 2244
2020
Q2 		– Sell
-4
Closed -$27.1K – 2057
2020
Q1 		$36K Buy
+4
New +$62.7K ﹤0.01% 1602

Other funds holding YARW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nisa Investment Advisors's YARW Position: Q3 2021 in Review

Nisa Investment Advisors sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2021, closing a stake of 1 share — an estimated $2 sold.

Nisa Investment Advisors first reported a position in YARW in Q1 2020 and held it in 4 quarters. The position peaked at $36K in Q1 2020. 58 funds tracked by Wall St. Rank hold YARW as of Q3 2021.

  • Nisa Investment Advisors reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 1 Yarrow Bioscience, Inc. Common Stock share in Q3 2021, an estimated $2.
  • Nisa Investment Advisors first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Nisa Investment Advisors's Yarrow Bioscience, Inc. Common Stock position peaked at $36K in Q1 2020.
  • 58 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.